NCT05849662 2026-04-15
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium
Phase 1/2 Recruiting
Therapeutic Advances in Childhood Leukemia Consortium
German Cancer Research Center
Sun Yat-sen University
Maastricht Radiation Oncology